Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 27, 2013	Sep. 28, 2012
Cash flows from operating activities:
Net loss	$ (19,938)	$ (19,722)
Adjustment to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	5,434	5,923
Stock incentive plan expense	1,396	1,324
Amortization and write-off of deferred loan costs	1,303	3,299
Amortization of debt discount	3,659	0
Payment-in-kind interest on debt	9,267	0
Change in fair value on warrant liability	2,878	0
Severance, impairment and other associated costs, net of cash payments	1,629	(1,368)
Other, net	432	(118)
Changes in assets and liabilities:
Accounts receivable	(4,017)	3,871
Inventory	(303)	5,272
Prepaid expenses and other current assets	(222)	(2,988)
Accounts payable and accrued expenses	3,732	(34)
Net cash provided by (used in) operating activities	5,250	(4,541)
Cash flows from investing activities:
Capital expenditures	(7,829)	(6,999)
Cash restricted due to litigation	(1,550)	0
Proceeds from sale of property, plant and equipment	534	591
Foreign currency impact on intercompany lending	(120)	(256)
Deposit received from pending divestiture	0	6,532
Net cash used in investing activities	(8,965)	(132)
Cash flows from financing activities:
Credit facility borrowings	0	11,000
Debt issuance costs	(1,700)	(1,584)
Change in restricted cash	(500)	0
Net cash (used in) provided by financing activities	(2,200)	9,416
Net effect of exchange rate changes on cash	20	(1)
Net (decrease) increase in cash and cash equivalents	(5,895)	4,742
Cash and cash equivalents at beginning of period	31,475	17,606
Cash and cash equivalents at end of period	25,580	22,348
Supplemental cash flows disclosures of non-cash investing and financing activity:
Capital expenditures included in accounts payable and accrued liabilities	325	1,500
Debt issuance costs included in accounts payable and accrued liabilities	$ 1,320	$ 0